Terms: = Colorectal cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217 AND Treatment
4 results:
1. Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer.
Carvalho RF; do Canto LM; Abildgaard C; Aagaard MM; Tronhjem MS; Waldstrøm M; Jensen LH; Steffensen KD; Rogatto SR
Cell Commun Signal; 2022 Nov; 20(1):176. PubMed ID: 36352420
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic value of syndecan-4 protein expression in colorectal cancer.
Jechorek D; Haeusler-Pliske I; Meyer F; Roessner A
Pathol Res Pract; 2021 Jun; 222():153431. PubMed ID: 34029877
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
Cadranel J; Liu SV; Duruisseaux M; Branden E; Goto Y; Weinberg BA; Heining C; Schlenk RF; Cheema P; Jones MR; Drilon A; Trombetta D; Muscarella LA; Tolba K; Gounant V; Cseh A; Solca F; Laskin JJ; Renouf DJ
Oncologist; 2021 Jan; 26(1):7-16. PubMed ID: 32852072
[TBL] [Abstract] [Full Text] [Related]
4. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
